SCREENS for Cancer Act of 2025
- Bill Number
- S. 1866
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-05-22: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Last Updated
- 2026-06-25T12:18:23Z
AI-Generated Summary
Purpose
The SCREENS for Cancer Act of 2025 aims to reauthorize and enhance the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), a federal initiative that provides cancer screening and related services to low-income, uninsured, or underinsured women. It extends the program through fiscal years 2026 to 2030, emphasizing prevention, equity, and expanded access to reduce breast and cervical cancer disparities.
Key Provisions
- Findings on Cancer Burden and Program Impact: The bill outlines 2025 projections of over 319,750 new invasive breast cancer cases and 43,000 deaths, plus 13,360 cervical cancer cases and 4,320 deaths. It highlights the NBCCEDP's history since 1991, including serving over 6.4 million people, delivering 16.5 million screenings, and diagnosing nearly 80,000 breast cancers and 5,300 cervical cancers, with a focus on outreach to isolated populations.
- Amendments to Program Purposes (Section 1501): Expands goals to include prevention alongside detection and control; adds requirements for support activities like patient navigation (guiding patients through healthcare), evidence-based strategies to boost screening rates, reducing disparities in high-risk populations, and improving equitable access by addressing barriers (e.g., cultural or geographic factors).
- Grant Requirements (Section 1503): Simplifies eligibility for states and territories by focusing on providing screenings and diagnostics aligned with evidence-based medical guidelines, while removing some prior administrative details.
- Reporting Changes (Section 1508): Shifts program evaluation reports from annual to every five years, starting two years after enactment, with data covering the preceding two or five fiscal years as applicable.
- Funding Authorization (Section 1510): Allocates $235 million annually for fiscal years 2026 through 2030 to support program operations.
- Government Accountability Office (GAO) Study (Section 4): Mandates a report by September 30, 2027, to Congress estimating eligible individuals, summarizing service trends, and assessing barriers to screening access.
Significant Changes to Existing Law
- Broader Scope: Adds "prevention" to the program's focus on detection and control, and introduces new priorities like disparity reduction and equitable access, which were not explicitly stated before.
- Streamlined Operations: Removes outdated or redundant language on follow-up services, case management, and initial grant conditions, making the program more flexible while ensuring evidence-based service delivery.
- Adjusted Oversight: Reduces reporting frequency from yearly to every five years to lessen administrative burden, but introduces a one-time GAO study for deeper analysis.
- Increased Funding Certainty: Extends and specifies annual funding levels beyond prior authorizations (which ended after 2011 in the original law), providing stable support through 2030.
Potential Impacts
- On Government Agencies: The Centers for Disease Control and Prevention (CDC), which administers the NBCCEDP, will receive sustained funding to expand services, potentially increasing screenings and early detections. Less frequent reporting may free resources for direct program delivery, while the GAO study could inform future improvements.
- On Citizens: Low-income, uninsured, or underinsured women—especially in underserved, rural, or minority communities—could benefit from more accessible screenings, navigation support, and reduced barriers, leading to earlier cancer diagnoses and fewer deaths. The program serves all 50 states, D.C., territories, and tribal organizations, broadening reach.
- On International Relations: Minimal direct impact, as the program is domestic-focused, though it may indirectly support global health equity discussions by demonstrating U.S. efforts in cancer prevention.
Main Stakeholders Affected
- Women at Risk: Primarily low-income, uninsured/underinsured women aged 21–64 eligible for cervical screenings and 40–64 for breast screenings, with emphasis on racially, ethnically, or geographically diverse groups facing higher cancer rates.
- Healthcare Providers and Organizations: State health departments, clinics, tribal entities, and nonprofits receiving grants to deliver screenings, diagnostics, education, and navigation services.
- Federal Agencies: CDC for program implementation; GAO for evaluation; congressional committees (Senate Health, Education, Labor, and Pensions; House Energy and Commerce) for oversight.
- Broader Public Health Community: Advocates, researchers, and cancer organizations benefiting from expanded data and reduced disparities.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens the Public Health Service Act by aligning it with modern evidence-based practices (e.g., from medical guidelines like those from the U.S. Preventive Services Task Force), potentially reducing legal challenges over outdated provisions. No major shifts in federal-state grant authority.
- Constitutional: Supports the federal government's role in public health under the Spending Clause (Article I, Section 8), funding state programs without infringing on states' rights, as participation remains voluntary.
- Political: Bipartisan sponsorship (e.g., by Sens. Baldwin, Collins, Cortez Masto, Klobuchar) signals broad support for women's health initiatives. Reauthorization amid rising cancer statistics could build momentum for health equity policies, though funding levels may spark debates on federal spending priorities. The GAO study promotes transparency, aiding future legislative adjustments without partisan overtones.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (7)
Sen. Collins, Susan M. [R-ME], Sen. Cortez Masto, Catherine [D-NV], Sen. Klobuchar, Amy [D-MN], Sen. Boozman, John [R-AR], Sen. Rounds, Mike [R-SD], Sen. Alsobrooks, Angela D. [D-MD], Sen. Ossoff, Jon [D-GA]
Recent Actions
- 2025-05-22: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-05-22: Introduced in Senate
Bill Versions
- Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act of 2025 — issued 2025-05-22 — PDF (7 pages)